Thrombosis Research
Volume 121, Issue 2 , Pages 163-174 , 2007

Different vulnerability of fibrinogen subunits to oxidative/nitrative modifications induced by peroxynitrite: Functional consequences

Received 15 November 2006 ,Revised 24 January 2007 ,Accepted 20 March 2007.

References 

  1. Stief TW, Kurz J, Doss MO, Fareed J. Singlet oxygen inactivates fibrinogen, factor V, factor VIII, factor X, and platelet aggregation of human blood. Thromb Res. 2000;97:473–480
  2. De CR, Rocca B, Marchioli R, Landolfi R. Plasma protein oxidation is associated with an increase of procoagulant markers causing an imbalance between pro- and anti-coagulant pathways in healthy subjects. Thromb Haemost. 2002;87:58–67
  3. Gugliucci A. Human plasminogen is highly susceptible to peroxynitrite inactivation. Clin Chem Lab Med. 2003;41:1064–1068
  4. Nielsen VG, Crow JP, Mogal A, Zhou F, Parks DA. Peroxynitrite decreases hemostasis in human plasma in vitro. Anesth Analg. 2004;99:21–26
  5. Nowak P, Kolodziejczyk J, Wachowicz B. Peroxynitrite and fibrinolytic system: the effect of peroxynitrite on plasmin activity. Mol Cell Biochem. 2004;267:141–146
  6. Vadseth C, Souza JM, Thomson L, Seagraves A, Nagaswami C, Scheiner T, et al. Pro-thrombotic state induced by post-translational modification of fibrinogen by reactive nitrogen species. J Biol Chem. 2004;279:8820–8826
  7. Hathuc C, Hermo R, Schulze J, Gugliucci A. Nitration of human plasminogen by RAW 264.7 macrophages reduces streptokinase-induced plasmin activity. Clin Chem Lab Med. 2006;44:213–219
  8. Shacter E, Williams JA, Levine RL. Oxidative modification of fibrinogen inhibits thrombin-catalyzed clot formation. Free Radic Biol Med. 1995;18:815–821
  9. Pignatelli B, Li CQ, Boffetta P, Chen Q, Ahrens W, Nyberg F, et al. Nitrated and oxidized plasma proteins in smokers and lung cancer patients. Cancer Res. 2001;61:778–784
  10. Selmeci L, Szekely M, Soos P, Seres L, Klinga N, Geiger A, et al. Human blood plasma advanced oxidation protein products (AOPP) correlates with fibrinogen levels. Free Radic Res. 2006;40:952–958
  11. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA. 1990;87:1620–1624
  12. Ischiropoulos H, Zhu L, Beckman JS. Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys. 1992;298:446–451
  13. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys. 1991;288:481–487
  14. Kooy NW, Royall JA, Ye YZ, Kelly DR, Beckman JS. Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respir Crit Care Med. 1995;151:1250–1254
  15. Akaike T, Noguchi Y, Ijiri S, Setoguchi K, Suga M, Zheng YM, et al. Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc Natl Acad Sci USA. 1996;93:2448–2453
  16. Fukuyama N, Takebayashi Y, Hida M, Ishida H, Ichimori K, Nakazawa H. Clinical evidence of peroxynitrite formation in chronic renal failure patients with septic shock. Free Radic Biol Med. 1997;22:771–774
  17. Salvemini D, Cuzzocrea S. Oxidative stress in septic shock and disseminated intravascular coagulation. Free Radic Biol Med. 2002;33:1173–1185
  18. Szabo C. Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett. 2003;140–141:105–112
  19. Ischiropoulos H, al Mehdi AB. Peroxynitrite-mediated oxidative protein modifications. FEBS Lett. 1995;364:279–282
  20. Gow A, Duran D, Thom SR, Ischiropoulos H. Carbon dioxide enhancement of peroxynitrite-mediated protein tyrosine nitration. Arch Biochem Biophys. 1996;333:42–48
  21. Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys. 1998;356:1–11
  22. Patel RP, McAndrew J, Sellak H, White CR, Jo H, Freeman BA, et al. Biological aspects of reactive nitrogen species. Biochim Biophys Acta. 1999;1411:385–400
  23. Buttery LD, Springall DR, Chester AH, Evans TJ, Standfield EN, Parums DV, et al. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of Peroxynitrite. Lab Invest. 1996;75:77–85
  24. Ishida Y, Takiuchi H, Matsushima A, Inada Y. Functional consequences of tryptophan modification in human fibrinogen. Biochim Biophys Acta. 1978;536:70–77
  25. Belisario MA, Di Domenico C, Pelagalli A, Della MR, Staiano N. Metal-ion catalyzed oxidation affects fibrinogen activity on platelet aggregation and adhesion. Biochimie. 1997;79:449–455
  26. Gole MD, Souza JM, Choi I, Hertkorn C, Malcolm S, Foust RF, et al. Plasma proteins modified by tyrosine nitration in acute respiratory distress syndrome. Am J Physiol, Lung Cell Mol Physiol. 2000;278:L961–L967
  27. Lipinski B. Pathophysiology of oxidative stress in diabetes mellitus. J Diabetes Complications. 2001;15:203–210
  28. Lupidi G, Angeletti M, Eleuteri AM, Tacconi L, Coletta M, Fioretti E. Peroxynitrite-mediated oxidation of fibrinogen inhibits clot formation. FEBS Lett. 1999;462:236–240
  29. Doolittle RF, Schubert D, Schwartz SA. Amino acid sequence studies on artiodactyl fibrinopeptides I Dromedary camel, mule deer, and cape buffalo. Arch Biochem Biophys. 1967;118:456–467
  30. Pryor WA, Squadrito GL. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol. 1995;268:L699–L722
  31. Bartosz G. Peroxynitrite: mediator of the toxic action of nitric oxide. Acta Biochim Pol. 1996;43:645–659
  32. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685
  33. Levine RL, Williams JA, Stadtman ER, Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol. 1994;233:346–357
  34. Heinecke JW, Li W, Daehnke HL, Goldstein JA. Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. J Biol Chem. 1993;268:4069–4077
  35. Takagi T, Doolittle RF. Amino acid sequence studies on plasmin-derived fragments of human fibrinogen: amino-terminal sequences of intermediate and terminal fragments. Biochemistry. 1975;14:940–946
  36. Szabo C. The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock. 1996;6:79–88
  37. Nowak P, Wachowicz B. Peroxynitrite-mediated modification of fibrinogen affects platelet aggregation and adhesion. Platelets. 2002;13:293–299
  38. Lee Y, Shacter E. Role of carbohydrates in oxidative modification of fibrinogen and other plasma proteins. Arch Biochem Biophys. 1995;321:175–181
  39. Lorenz M, Muller M, Jablonka B, Vigh T, Kirchmaier CM. High doses of methylene blue/light treatment crosslink the A-alpha-subunit of fibrinogen: influence of this photooxidization on fibrinogen binding to platelets. Haemostasis. 1998;28:17–24
  40. York JL, Blomback B. The sites of the lactoperoxidase-catalyzed iodination of human fibrinogen. J Biol Chem. 1979;254:8786–8795
  41. Ischiropoulos H. Biological selectivity and functional aspects of protein tyrosine nitration. Biochem Biophys Res Commun. 2003;305:776–783
  42. MacMillan-Crow LA, Crow JP, Thompson JA. Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues. Biochemistry. 1998;37:1613–1622
  43. van der Vliet A, Hristova M, Cross CE, Eiserich JP, Goldkorn T. Peroxynitrite induces covalent dimerization of epidermal growth factor receptors in A431 epidermoid carcinoma cells. J Biol Chem. 1998;273:31860–31866
  44. Souza JM, Giasson BI, Chen Q, Lee VM, Ischiropoulos H. Dityrosine cross-linking promotes formation of stable alpha-synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. J Biol Chem. 2000;275:18344–18349
  45. Thiagarajan G, Lakshmanan J, Chalasani M, Balasubramanian D. Peroxynitrite reaction with eye lens proteins: alpha-crystalline retains its activity despite modification. Invest Ophthalmol Vis Sci. 2004;45:2115–2121
  46. Reynolds MR, Berry RW, Binder LI. Site-specific nitration and oxidative dityrosine bridging of the tau protein by peroxynitrite: implications for Alzheimer's disease. Biochemistry. 2005;44:1690–1700
  47. Kaplan IV, Attaelmannan M, Levinson SS. Fibrinogen is an antioxidant that protects beta-lipoproteins at physiological concentrations in a cell free system. Atherosclerosis. 2001;158:455–463
  48. Olinescu RM, Kummerow FA. Fibrinogen is an efficient antioxidant. J Nutr Biochem. 2001;12:162–169
  49. Inada Y, Hessel B, Blomback B. Photooxidation of fibrinogen in the presence of methylene blue and its effect on polymerization. Biochim Biophys Acta. 1978;532:161–170
  50. Cierniewski CS, Budzynski AZ. Involvement of the alpha chain in fibrin clot formation. Effect of monoclonal antibodies. Biochemistry. 1992;31:4248–4253
  51. Veklich YI, Gorkun OV, Medved LV, Nieuwenhuizen W, Weisel JW. Carboxyl-terminal portions of the alpha chains of fibrinogen and fibrin localization by electron microscopy and the effects of isolated alpha C fragments on polymerization. J Biol Chem. 1993;268:13577–13585
  52. Credo RB, Curtis CG, Lorand L. Alpha-chain domain of fibrinogen controls generation of fibrinoligase (coagulation factor XIIIa) Calcium ion regulatory aspects. Biochemistry. 1981;20:3770–3778
  53. Cheresh DA, Berliner SA, Vicente V, Ruggeri ZM. Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. Cell. 1989;58:945–953
  54. Sakata Y, Aoki N. Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. J Clin Invest. 1980;65:290–297
  55. Ritchie H, Lawrie LC, Crombie PW, Mosesson MW, Booth NA. Cross-linking of plasminogen activator inhibitor 2 and alpha 2-antiplasmin to fibrin(ogen). J Biol Chem. 2000;275:24915–24920
  56. Tsurupa G, Medved L. Identification and characterization of novel tPA- and plasminogen-binding sites within fibrin(ogen) alpha C-domains. Biochemistry. 2001;40:801–808
  57. Lijnen HR, Soria J, Soria C, Collen D, Caen JP. Dysfibrinogenemia (fibrinogen Dusard) associated with impaired fibrin-enhanced plasminogen activation. Thromb Haemost. 1984;51:108–109
  58. Koopman J, Haverkate F, Grimbergen J, Egbring R, Lord ST. Fibrinogen Marburg: a homozygous case of dysfibrinogenemia, lacking amino acids A alpha 461-610 (Lys 461 AAA−>stop TAA). Blood. 1992;80:1972–1979
  59. Weisel JW, Nagaswami C. Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled. Biophys J. 1992;63:111–128
  60. Fatah K, Hamsten A, Blomback B, Blomback M. Fibrin gel network characteristics and coronary heart disease: relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis. Thromb Haemos. 1992;68:130–135
  61. Fatah K, Silveira A, Tornvall P, Karpe F, Blomback M, Hamsten A. Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age. Thromb Haemost. 1996;76:535–540
  62. Langer BG, Weisel JW, Dinauer PA, Nagaswami C, Bell WR. Deglycosylation of fibrinogen accelerates polymerization and increases lateral aggregation of fibrin fibers. J Biol Chem. 1988;263:15056–15063
  63. Pennathur S, Jackson-Lewis V, Przedborski S, Heinecke JW. Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o′-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease. J Biol Chem. 1999;274:34621–34628
  64. Monaco S, Gioia M, Rodriguez J, Fasciglione GF, Di Pierro D, Lupidi G, et al. Modulation of the proteolytic activity of matrix metalloproteinase-2 (Gelatinase A) on fibrinogen. Biochem J. 2007;402:503–513
  65. Lipinski B. Dityrosine crosslinking of fibrin(ogen) may offer additional protection of tumor cells against immune killing. Oncology. 2001;60:373–374

PII: S0049-3848(07)00120-X

doi: 10.1016/j.thromres.2007.03.017

Thrombosis Research
Volume 121, Issue 2 , Pages 163-174 , 2007

Article Tools

* Image Usage & Resolution